# Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults

> **NCT01086449** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** Herpes Zoster Vaccine GSK 1437173A

## Key facts

- **NCT ID:** NCT01086449
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-04
- **Primary completion:** 2010-06-25
- **Final completion:** 2010-11-25
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01086449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01086449, "Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01086449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*